Pfizer Announces Q3 2025 Earnings Call and Performance Report Release

Pfizer invites investors and the public to view a webcast of its conference call with analysts on November 4, 2025. The call will provide an update on Pfizer's Q3 2025 Performance Report, set to be released that morning. The webcast will be available on Pfizer's website, and participants can register in advance to listen to the call. The transcript and replay will be available within 24 hours.

Pfizer Inc. (NYSE: PFE) has announced that it will host a webcast conference call with analysts on November 4, 2025, to provide an update on its Q3 2025 Performance Report. The report is set to be released that morning. Investors and the public are invited to view and listen to the webcast, which will be available on Pfizer's official website. Participants can register in advance to ensure they do not miss the call.

The webcast is scheduled to begin at 8:00 AM EDT and will include a live presentation by Pfizer executives. The transcript and replay of the call will be made available within 24 hours after the live event and will remain accessible for at least 90 days. For those unable to attend the live webcast, the replay will be available on Pfizer's website at www.pfizer.com/investors.

In addition to the Q3 2025 Performance Report, the webcast will provide updates on Pfizer's recent strategic initiatives, including its acquisition of Metsera Inc. (NASDAQ: MTSR). The acquisition, valued at $47.50 per Metsera share in cash, aims to add four highly differentiated clinical-stage incretin and amylin programs to Pfizer's pipeline. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions and regulatory approvals Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio^[1].

Investors are encouraged to pre-register for the webcast to avoid operator hold times and to access the necessary information promptly. For more details on the webcast, including how to register, visit Pfizer's investor relations page at www.pfizer.com/investors.